Coastal Meds Recalls LIPO-B Injectable Due to Particulate Matter
Coastal Meds, LLC. is recalling LIPO-B Injectable-30 mL vials due to the presence of unknown particulate matter.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of unknown particulate matter in an injectable drug represents a risk of harm where injury has not yet been reported.
Plain-English summary
Coastal Meds, LLC. is recalling 3,959 vials of LIPO-B Injectable-30 mL. The recall is being conducted because of the presence of unknown particulate matter in the product.
The affected lots were distributed nationwide in the USA. The specific lot numbers and discard dates are: LB/100517 (Discard by 4/3/2018), LB/111717 (Discard by 5/16/2018), LB/120717 (Discard by 6/5/2018), LB/010418 (Discard by 7/3/2018), LB/012618 (Discard by 7/25/2018), LB/022118 (Discard by 8/20/2018), CALB/012918 (Discard by 3/30/2018), and CALB/021218 (Discard by 4/13/2018).
Consumers and healthcare providers should stop using the affected product and contact Coastal Meds, LLC. for further instructions or a refund.
The recalled product
- Product
- LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
- Manufacturer
- Coastal Meds, LLC.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 3,959
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lots: LB/100517 Discard by 4/3/2018
- LB/111717 Discard by 5/16/2018
- LB/120717 Discard by 6/5/2018
- LB/010418 Discard by 7/3/2018
- LB/012618 Discard by 7/25/2018
- LB/022118 Discard by 8/20/2018
- CALB/012918 Discard by 3/30/2018
- CALB/021218 Discard by 4/13/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Coastal Meds, LLC. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Coastal Meds, LLC.
See all →- SevereCoastal Meds Recalls LIPO-DEN PLUS Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- HighFDA Recalls LIPO-DEN Injectable Due to Unknown Particulate Matter
FDA (Drugs) · 2018-05-02
- HighCoastal Meds Recalls Methylcobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereCoastal Meds Recalls Hydroxocobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereCoastal Meds Recalls Pyridoxine Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- ModerateMcGuff Compounding Pharmacy Recalls Lipoic Acid Injection Due to Particulate Matter
FDA (Drugs) · 2020-01-22
- SevereMylan Recalls Carboplatin Injection Due to Particulate Matter
FDA (Drugs) · 2015-08-26
- HighInjectable Vitamin B Vials Recalled for Particulate Matter Contamination
FDA (Drugs) · 2023-02-22
- CriticalBristol-Myers Squibb Recalls Coumadin for Injection Due to Particulate Matter
FDA (Drugs) · 2014-09-24
- CriticalMylan Recalls Gemcitabine Injection Vials Due to Particulate Matter
FDA (Drugs) · 2015-08-26
- CriticalMethotrexate Injection Recalled Due to Presence of Particulate Matter
FDA (Drugs) · 2015-08-19